CRISPR/Cas9 a genetic practise
The use of CRISPR/Cas9 , to which we have often referred in Bioethics News (see HERE), in reference to the fact that it could be used to cure diseases due to an alteration in a single gene, is being investigated to treat haemophilia and other hereditary diseases. An article has now been published (Science (2015) DOI:101126/Science. aad5143) on its use for treating Duchenne muscular dystrophy in mice, which undoubtedly paves the way for its possible use in humans. If so, diseases like haemophilia, Huntington disease and other diseases caused by the alteration of a single gene could be treated by CRISP/Cas9.
La entrada CRISPR/Cas9 for the treatment of haemophilia and other hereditary diseases is being investigated aparece primero en Observatorio de Bioética, UCV.
The views, opinions and positions expressed by these authors and blogs are theirs and do not necessarily represent that of the Bioethics Research Library and Kennedy Institute of Ethics or Georgetown University.